← SynDRA
REMOXIPRIDE
SynDRA canonical compound SYN0001309 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Primary target(s) | DRD2 |
| Mechanism of action | Dopamine receptor antagonist |
All known targets
- DRD2
- DRD3
- DRD4
- HTR2A
- SIGMAR1
- Drd1
- Drd2
- Drd3
- Drd4
- Drd5
- HTR1A
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Neurotransmitter Agents
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
Cross-references
Synonyms
- (S)-Remoxipride
- remoxipride hydrochloride
- remoxipride HCl
- Remoxiprida
- A-33547
- A 33547.HCL.H20
- FLA-731
- FLA-731 FREE BASE
- FLA 731(-)
- Remoxipridum
- Romoxipride
- Remoxiprida [INN-Spanish]
- Remoxipride (USAN)
- Remoxipridum [INN-Latin]
- Remoxipride [USAN:BAN:INN]
- (-)-(S)-3-Brom-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamid
- (-)-(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide
- (-)-n-ethyl-2-(3-bromo-2,6-dimethoxybenzamidomethyl)pyrrolidine
- (S)-3-Bromo-2,6-dimethoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
- (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide
- 3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide
- FLA 731
- Roxiam
- (S)-3-Bromo-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dimethoxybenzamide
- CHEMBL22242
- 0223RD59PE
- 80125-14-0 (free base)
- Benzamide, 3-bromo-2,6-dimethoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)-, (S)-
- Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxy-, (S)-
- FLA-731(-)
- NCGC00024870-02
- REMOXIPRIDE [USAN]
- 3-bromo-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2,6-dimethoxybenzamide
- CAS-80125-14-0
- BRN 4323708
- UNII-0223RD59PE
- Remoxipride [USAN:INN:BAN]
- Tocris-0916
Look up REMOXIPRIDE in the interactive SynDRA portal →